Expiration Date: 1/03/2024
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Gina M. Solomon, MD, MPH
Clinical Professor of Medicine
U.C. San Francisco
Beckye Stanton, Ph.D
Office of Environmental Health Hazard Assessment, California Environmental Protection Agency
Moderator & Organizer
David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
During June–November 2021, cyanobacteria harmful algal blooms occurred in Clear Lake, CA. These blooms resulted in microcystin contamination of tap water in homes with lake water intakes, in some cases exceeding EPA drinking water health advisory levels. Microcystins can cause hepatotoxicity, gastroenteritis, dermatitis, and allergic reactions. This webinar will discuss signs and symptoms of microcystin toxicity, identify major microcystin exposure sources in humans, and discuss ways to reduce harmful exposures to microcystin.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives – After attending this program you should be able to:
- Recognize signs and symptoms of microcystin toxicity and how to report potentially related illnesses
- Identify at least three major microcystin exposure sources in humans
- Advise patients and communities on at least three ways to reduce harmful exposures to microcystin
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.